TUESDAY, JULY 25, 2017

Inactivated Polio Vaccine launched in Nepal

Health officials with the World Health Organization (WHO), UNICEF, and Nepal's Department of Health Services and Child Health Division recently launched the Inactivated Polio Vaccine (IPV) in the South Asian nation. Read More »

Outdated practices stall drug-resistant TB fight

Leaders from Doctors Without Borders (MSF) and the Stop TB Partnership recently published the second part of the report titled "Out of Step," which was previously an outdated resource that allowed drug-resistant tuberculosis (TB) to continue spreading. Read More »

New measles vaccine could save millions

A recent study demonstrates an innovative measles and rubella vaccine, which has received approval from the Board of Gavi (the Vaccine Alliance), is effective enough to help save over a million people. Read More »

Texas Biomed gains grant to develop cure for HIV-born babies

The Texas Biomedical Research Institute (TBRI) recently gained a $5 million National Institutes of Health grant to fund the organization’s research for potential functional cures for babies who are born with human immunodeficiency virus (HIV) infections. Read More »

Pakistani official calls for mandatory polio vaccines

Pakistani Sen. Ayesha Raza Farooq, the prime minister’s focal person on polio, recently said there must be mandatory vaccinations to fully eliminate poliovirus from Pakistan. Read More »

Study shows accurate portrayal of meningitis decline in England

Recent research from the national surveillance program shows an accurate portrayal of the ongoing decline in the number of meningococcal disease cases reported throughout England. Read More »

Trial applications sought for FIND and Cepheid diagnosis tools

FIND and Cepheid recently requested trial applications to evaluate the effect and performance of diagnosing rifampicin resistance and tuberculosis (TB) using the GeneXpert Omni system from Cepheid when it is used along with the Xpert MTB/RIF Ultra assay. Read More »

NIH researchers create HIV prevention and treatment guidelines

National Institutes of Health (NIH) researchers at the National Institute of Allergy and Infectious Diseases (NIAID) recently used three clinical studies to create guidelines for preventing and treating HIV infections. Read More »

BiondVax launches universal flu vaccine

BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company based in Israel that creates and markets immunomodulation therapies to treat infectious diseases, recently launched a universal vaccine onto the market. Read More »

Asian officials issue update on dengue virus

Health professionals recently released the latest report on dengue fever in China and the surrounding Pacific region. Read More »

Study shows risky sex more likely in young men with HIV

Scientists at Columbia University's Mailman School of Public Health recently conducted a study that shows young men who have detectable HIV are much more likely to engage in risky sexual acts than young men who have attained virological suppression. Read More »

Army taps Hawaii Biotech to create vaccine for dengue fever

The U.S. Army Small Business Innovative Research (SBIR) Program recently awarded Hawaii Biotech Inc. an SBIR Phase I contract to create a vaccine to protect military personnel from dengue fever. Read More »

Influenza virus research designed to boost vaccine efficiency

University of Helsinki scientists recently conducted a study that better predicts which influenza viruses will be circulating for the flu season, which will help researchers develop more effective vaccines. Read More »

Improved toolkit provides differentiated care for HIV and TB patients

The Global Fund recently developed an improved toolkit that will help health care workers provide human immunodeficiency virus (HIV) and tuberculosis (TB) patients with improved differentiated care. Read More »

Pennsylvanians can receive low- or no-cost flu shots

The Pennsylvania Department of Health is offering eligible local residents either low or no-cost influenza vaccines through Friday. Read More »

Yale scientists seek to protect cancer patients from flu

Yale Cancer Center scientists have created a vaccine strategy to protect cancer patients -- considered to be at the highest risk for developing influenza infections -- against the flu. Read More »

Scripps researchers journey toward specific TB treatments

One-third of the world’s population is infected with a type of tuberculosis (TB) infection where the causative bacteria, M. tuberculosis (Mtb), lies in a dormant or persistent form, making it untreatable with available anti-TB drugs, according to Kate Carroll, an associate professor of chemistry at the Scripps Research Institute in Jupiter, Florida. Read More »

Harvard team discovers new ways to study viruses

Researchers from Harvard University’s John A Paulson School of Engineering and Applied Sciences have found new ways to study viruses, which may help to create better treatments and vaccines. Read More »

Avian influenza detected in France

The European Centres for Disease Control and Prevention (ECDC) recently released a rapid risk assessment because of avian influenza subtype H5, which has been detected in a flock of domestic birds in France. Read More »

Altered mosquitoes may benefit efforts against malaria

Altering mosquitoes that are infected with malaria so that they are infertile may stop the parasitic trait from passing on to the next generation of mosquitoes, potentially eliminating malaria. Read More »